The Advisory Board Company recap’s yesterday’s MIPS and APM incentive proposed rule.
Leidos reports Q1 results: revenue grew five percent to $1.31 billion vs. $1.25 billion in the same quarter last year, adjusted EPS $0.72 vs. $0.67. Executives announced that
Athenahealth reports Q1 results: revenue climbed 24 percent to $256 million vs. 206 million in the same quarter last year, EPS $0.34 vs. $0.24, beating expectations on both.
The FDA has rejected Proteus Digital Health’s request to embed smart sensors designed to track medication compliance into Otsuka’s antipsychotic medication Abilify.